Siga Technologies (SIGA) Common Equity (2010 - 2025)
Siga Technologies' (SIGA) quarterly Common Equity came in at $198.8 million in Q4 2025, down 7.87% YoY from $215.8 million in Q4 2024, and down 2.29% on a QoQ basis from $203.5 million in Q3 2025.
Siga Technologies (SIGA) Common Equity (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Common Equity data on file, last reported at $198.8 million in Q4 2025.
- Quarterly Common Equity fell 7.87% year-over-year to $198.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $198.8 million (down 7.87% YoY) and the FY2025 annual result came in at $198.8 million, down 7.87% from the prior year.
- Common Equity declined to $198.8 million in Q4 2025, from $203.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $216.1 million in Q1 2025 to a low of $106.6 million in Q3 2021.
- A 5-year average of $166.2 million and a median of $168.6 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity surged 62.49% — and 2023, when it dropped 28.3%.
- Tracing SIGA's Common Equity over 5 years: stood at $174.3 million in 2021, then declined by 2.38% to $170.2 million in 2022, then grew by 15.69% to $196.9 million in 2023, then increased by 9.62% to $215.8 million in 2024, then fell by 7.87% to $198.8 million in 2025.
- The last three Common Equity figures came in at $198.8 million (Q4 2025), $203.5 million (Q3 2025), and $209.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Siga Technologies | 213.38 Mn | 58.42 Mn | - | 198.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 198.82 Mn |
| Sep 30, 2025 | 203.48 Mn |
| Jun 30, 2025 | 209.31 Mn |
| Mar 31, 2025 | 216.13 Mn |
| Dec 31, 2024 | 215.80 Mn |
| Sep 30, 2024 | 169.44 Mn |
| Jun 30, 2024 | 167.56 Mn |
| Mar 31, 2024 | 164.99 Mn |
| Dec 31, 2023 | 196.86 Mn |
| Sep 30, 2023 | 124.14 Mn |
| Jun 30, 2023 | 124.07 Mn |
| Mar 31, 2023 | 162.09 Mn |
| Dec 31, 2022 | 170.16 Mn |
| Sep 30, 2022 | 173.14 Mn |
| Jun 30, 2022 | 139.77 Mn |
| Mar 31, 2022 | 167.74 Mn |
| Dec 31, 2021 | 174.31 Mn |
| Sep 30, 2021 | 106.56 Mn |
| Jun 30, 2021 | 116.72 Mn |
| Mar 31, 2021 | 122.68 Mn |